Nile Pharmaceuticals
NIPHFiscal year starts in July · currency EGP · latest: Q1 2026
Net profit · 2024
90.23million
▼ 24.3% vs 2023
Total assets · 2024
1.47billion
▲ 41.9% vs 2023
Shareholders' equity · 2024
469million
▼ 2.0% vs 2023
Operating cash flow · 2024
264million
▲ 203.0% vs 2023
Key facts
Source: annual statements 2024- Nile Pharmaceuticals's net profit in 2024 was 90.23 million EGP, down 24.3% from 119 million EGP in 2023.
- Total assets at the end of 2024 were 1.47 billion EGP, and shareholders' equity 469 million EGP.
- Operating cash flow in 2024 was positive at 264 million EGP.
AI summary
Preparing a summary of the latest results…
Ask about Nile Pharmaceuticals
How much did Nile Pharmaceuticals's net profit grow last year?What were total assets and shareholders' equity in the latest annual balance sheet?Was operating cash flow positive in the last three years?Type your question…Ask3 free questions a day after signing up. With Google, no password.
Annual net profit last 4 years
Net profit64.42million
89.67million
119million
90.23million
2021202220232024
Summarised financial statements
Swipe the table to see the other years.
Item · EGP2021202220232024
Income statement
Net profit64.42 million89.67 million119 million90.23 million
Gross profit502 million535 million595 million583 million
Total assets720 million769 million1.04 billion1.47 billion
Total liabilities349 million339 million560 million1 billion
Shareholders' equity371 million431 million478 million469 million
Total liabilities and equity720 million769 million1.04 billion1.47 billion
Operating cash flow79.47 million4.91 million-256 million264 million
Investing cash flow-4.29 million-48 million-27.52 million-420 million
Financing cash flow-45.2 million-12.62 million273 million303 million
Net change in cash29.99 million-55.71 million-11.38 million148 million
Sign up free to see the full five years for every period.
Sign up free in secondsWith Google or your email, no password.
Figures in Egyptian pounds from the published statement summaries, after normalising reporting units across periods. The exact figure is in the attached report.
Financial reports (14)
Other companies in Health Care & Pharmaceuticals
Ranked by latest annual net profit
